Project Grant R01MH133728

Award Date 8/1/24
Completion Date 2/28/29
Dollars Obligated $2M
Federal Grant Program
93.242
Assistance Type
Project Grant
Place of Performance
West Haven, CT 06516, USA
Similar Awards
This $2,220,017.04 Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), aims to conduct a large-scale, single-cell characterization of the molecular and cellular networks underlying mood regulation circuitry in major depressive disorder (MDD). The key objectives are to: 1) Identify transcriptomic changes associated with MDD at the single-cell level across three brain regions - the anterior cingulate cortex,...
The National Institute of Mental Health (NIMH) awarded a $593,104 Project Grant (CFDA 93.242 - Mental Health Research Grants) to Virginia Commonwealth University (VCU) to conduct research on the risk pathways to major depression. The project aims to advance the etiological understanding of major depression by clarifying the interrelationships between genetic and environmental risk factors over time, leveraging data from the extensive national health registers in Denmark and Sweden. Key...
The National Institutes of Health National Institute of Mental Health awarded Yale University $7,389,444 under the Mental Health Research Grants program (CFDA 93.242) on September 1, 2022 for a project concluding on August 31, 2025. The award will support Yale University in conducting a multivariate investigation to identify latent factors linking internalizing disorders such as anxiety, major depressive disorder, and posttraumatic stress disorder with COVID-19 outcomes including infection,...
This $535,153 Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will support a large-scale, single-cell characterization of molecular and cellular networks regulating mood in major depressive disorder (MDD). The research, conducted by the Centre de Recherche de l'Hôpital Douglas in Canada, aims to identify transcriptomic changes associated with MDD in the anterior cingulate cortex, basolateral amygdala, and...
This $1,932,991 Project Grant awarded by the National Institute of Mental Health (CFDA 93.242 Mental Health Research Grants) supports research at Yale University to investigate neural computations underlying learning, decision-making, and memory, and their associations with symptoms of anxiety and stress-related disorders. The project aims to characterize core computations of value, uncertainty, and prediction error across cognitive processes and reward/punishment domains, both behaviorally...
This federal Project Grant award of $418,750 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) supports research to mechanistically uncover the neuroanatomical substrates of anxiety-related brain circuits in humans. The research team at Yale University will use invasive neurophysiology and direct electrical brain stimulation to study the individual and complementary roles of the dorsal anterior cingulate cortex and anterior insula...
The National Institute of Mental Health (NIMH) awarded a $11,737,873 Cooperative Agreement under the Mental Health Research Grants program (CFDA 93.242) to the Icahn School of Medicine at Mount Sinai. The project, titled "Phenotypes Reimagined to Define Clinical Treatment and Outcome Research (PREDICTOR)", aims to develop clinical signatures for predicting key mental health outcomes in young adults seeking treatment for the first time. The project will analyze behavioral data from...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), will fund the development of a portable, low-cost, point-of-care microfluidic system for rapid pharmacogenomic screening of patients with major depressive disorder (MDD). The $3,392,617 award to the Rector & Visitors of the University of Virginia will enable the creation of a device that can quickly determine a patient's metabolizer status for selective...
The National Institute of Mental Health (NIMH) awarded a $782,271 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to the University of California, Los Angeles (UCLA) with a project period from September 1, 2024 to May 31, 2029. The grant, titled "PSYCHEMERGE: ADVANCING PRECISION PSYCHIATRY," aims to develop a nationwide federated transfer-learning platform for generalizable and bias-aware psychiatric diagnostic algorithms, integrate advanced genomic and...
This federal Project Grant award of $424,175 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) aims to better understand the genomic basis of post-traumatic stress disorder (PTSD). The research, conducted by Virginia Commonwealth University (VCU), will leverage existing large-scale whole exome sequencing (WES) and whole genome sequencing (WGS) datasets from the UK Biobank and All of Us Study to identify additional genetic signals...

This $1,995,095 Project Grant awarded by the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), supports a research project led by Yale University to expand the genetic understanding of major depressive disorder (MDD) and anxiety disorders (ANX). The project will leverage the large, diverse Veterans Affairs Million Veteran Program (MVP) dataset to conduct gene discovery analyses, investigate medication response genetics, and examine relationships between MDD, ANX, and other related traits like cardiovascular disease. The findings are expected to advance the repositioning of approved medications and identify novel treatment targets for these highly prevalent mental health conditions. The award period runs from August 1, 2024 to February 28, 2029.

Generated 6/24/25, 6:27 AM